NEW YORK (GenomeWeb) – Canadian informatics firm Cyclica has completed a C$2.4 million (approximately $1.8 million) Series A financing round led by Toronto-based finance advisory firm GreenSky Capital with additional investments from existing and new investors including the China Canada Angel Alliance and the Anthony Griffiths family.

The funding will help Cyclica scale up its sales and marketing efforts as well as support continued product development, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.